Evidence map›Paper›PMID 31529717›Full record

ArticleDiabetic medicine : a journal of the British Diabetic Association2020

Severe neonatal hypoglycaemia and intrapartum glycaemic control in pregnancies complicated by type 1, type 2 and gestational diabetes.

J M Yamamoto, L E Donovan, K Mohammad, S L Wood

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Diabetic medicine : a journal of the British Diabetic Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05647798 (Management of Intrapartum Glycemia in Gestational Diabetic Mothers), which is not on this map. Cited by 22 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 4 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05647798 naterminatednot on this mapstarted 2023, after this paper: background citation

Management of Intrapartum Glycemia in Gestational Diabetic Mothers: A Randomized Controlled Trial

TypeinterventionalSponsorInova Health Care ServicesRan2023 to 2024Enrolled2ConditionsPregnancy, Gestational Diabetes Mellitus, Class A2, Neonatal HypoglycemiaArmsBlood sugar check every 2 hours, Blood sugar check every 4 hours
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 4 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Neonatal Glycemic Status in Infants of Diabetic Mothers in Sulaimaniyah Governorate, Iraq.International journal of endocrinology and metabolism · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Glycaemic control in labour with diabetes: GILD, a scoping study.Health technology assessment (Winchester, England) · 2025
    Article
  11. Article
  12. Intrapartum Glycemic Control and Clinical Outcomes.Diabetes spectrum : a publication of the American Diabetes Association · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Observational
  18. Review
  19. Reexamining intrapartum glucose control in patients with diabetes and risk of neonatal hypoglycemia.Journal of perinatology : official journal of the California Perinatal Association · 2021
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

J M YamamotoDepartment of Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada.ORCID 0000-0002-3556-0820
L E DonovanDepartment of Medicine, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada.
K MohammadSection of Neonatology, Department of Paediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
S L WoodDepartment of Obstetrics and Gynaecology, University of Calgary, Cumming School of Medicine, Calgary, Alberta, Canada.
University of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo determine if in-target intrapartum glucose control is associated with neonatal hypoglycaemia in women with type 1, type 2 or gestational diabetes.

methodsThis was a retrospective cohort study of pregnant women with diabetes and their neonates. The primary exposure was in-target glucose control, defined as all capillary glucose values within the range 3.5-6.5 mmol/l during the intrapartum period. The primary outcome, neonatal hypoglycaemia, was defined as treatment with intravenous dextrose therapy. Multiple logistic regression was used to examine the association between maternal intrapartum glycaemic control and neonatal hypoglycaemia, adjusting for covariates.

resultsIntrapartum glucose testing was available for 157 (86.3%), 267 (76.3%) and 3256 (52.4%) women with type 1, type 2 and gestational diabetes, respectively. In the univariate analysis, in-target glycaemic control was significantly associated with neonatal hypoglycaemia in women with gestational diabetes, but not in women with type 1 or 2 diabetes. However, after adjustment for important neonatal factors (large for gestational age, preterm delivery and infant sex), intrapartum in-target glycaemic control was not significantly associated with neonatal hypoglycaemia in women regardless of diabetes type [adjusted odds ratios 0.4 (95% CI 0.1, 1.4), 0.7 (95% CI 0.3, 1.3) and 0.7 (95% CI 0.5, 1.0) for women with type 1, type 2 and gestational diabetes, respectively].

conclusionsThere was no significant association between in-target glycaemic control and neonatal hypoglycaemia after adjustment for neonatal factors. Given the high risk of maternal hypoglycaemia and the resources required, future trials should consider whether more relaxed intrapartum glycaemic targets may be safer and yield similar neonatal outcomes.

Indexed as

Diabetes, GestationalAdultBlood GlucoseCohort StudiesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FemaleGestational AgeGlycemic ControlHumansHyperglycemiaHypoglycemiaInfant, NewbornInfant, Newborn, DiseasesPregnancyRetrospective StudiesBlood Glucose

Identifiers

PMID31529717
PMCPMC6916340
OpenAlexW2973779680

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.